China Pharma (NYSE:CPHI) Shares Down 1.6% – Time to Sell?

China Pharma Holdings, Inc. (NYSE:CPHI) shares fell 1.6% during trading on Tuesday . The company traded as low as $0.5604 and last traded at $0.6148. 296,705 shares were traded during mid-day trading, a decline of 32% from the average daily volume of 439,533 shares. The stock had previously closed at $0.6250.

China Pharma Price Performance

The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. The company has a market cap of $24.91 million, a PE ratio of -1.12 and a beta of 1.14. The firm has a 50 day moving average of $0.74 and a two-hundred day moving average of $0.79.

Institutional Investors Weigh In On China Pharma

An institutional investor recently raised its stake in China Pharma stock. Citadel Advisors LLC lifted its stake in China Pharma Holdings, Inc. (NYSE:CPHI) by 31.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,426 shares of the company’s stock after purchasing an additional 7,356 shares during the quarter. Citadel Advisors LLC owned 0.93% of China Pharma worth $59,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension.